Company · Ownership research

Arcutis Biotherapeutics, Inc. ARQT

CIK 0001787306

Form 4 transactions dated Nov 1, 2023 to Nov 13, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 46 rows; the complete set is available through the API.

Insider filings on file run through Nov 4, 2026.

Insider purchases & sales

Purchased: $620.59K
Sold: $28.55M

Nov 1, 2023 – Nov 4, 2026
Available records · partial months are marked ·

202610 of 30 preview events · 46 available in 2026

Date	Insider	Activity	Trade value (USD)	% of prior holding
Nov 4, 2026	Matsuda Masaru EVP, Chief Legal Officer	Sale10b5-1 footnote	$1.37M 40,000 shares sold	26.44% sold Direct holding	▾
Nov 2, 2026	Matsuda Masaru EVP, Chief Legal Officer	Sale	$38.84K 1,219 shares sold	1.08% sold Direct holding	▾
Nov 2, 2026	Burnett Patrick EVP, Chief Medical Officer	Sale	$30.05K 943 shares sold	0.80% sold Direct holding	▾
Nov 2, 2026	Watanabe Todd See Remarks · Director	Sale	$139.47K 4,377 shares sold	0.61% sold Direct holding	▾
Oct 15, 2026	Welgus Howard G. Director	Sale10b5-1 footnote	$127.33K 4,728 shares sold	11.84% sold Direct holding	▾
Sep 16, 2026	Matsuda Masaru See Remarks	Sale10b5-1 footnote	$91.85K 3,674 shares sold	3.16% sold Direct holding	▾
Sep 15, 2026	Welgus Howard G. Director	Sale10b5-1 footnote	$114.37K 4,730 shares sold	11.66% sold Direct holding	▾
Sep 8, 2026	Matsuda Masaru See Remarks	Sale10b5-1 footnote	$249.99K 9,989 shares sold	7.92% sold Direct holding	▾
Aug 27, 2026	Curran Terrie Director	Sale	$956.12K 38,200 shares sold	Unavailable Direct holding	▾
Aug 20, 2026	Curran Terrie Director	Sale	$27.91K 1,072 shares sold	4.36% sold Direct holding	▾

Showing 30 / 46 record groups in 2026. The complete set is available through the API.

Arcutis Biotherapeutics, Inc. · ARQT

Follow the people behind the trades.

Log in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 46 purchase / sale groups and 30 of 64 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP / CLI.

MCP  https://api.akkrudata.ai/mcp

akkru_insider_transactions
{"action":"list","ticker":"ARQT","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP / CLI documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Share totals are on today's split-adjusted basis. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.